← Evidence map

ReviewBritish journal of cancer2015

The development of PARP inhibitors in ovarian cancer: from bench to bedside.

Yvette DrewPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

29 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 26669452